Dr. Tianyu Zhang from Carnegie Mellon University will discuss a new polygenic score framework and how it may benefit underrepresented populations..

With the progression of genetic technologies, it is important to understand not only what technologies are available but also the range of results that they provide and how to interpret those results. From positive and negative results to secondary and novel findings, what information can these provide to patients and researchers/clinicians? Using anonymized clinical reports, the speakers will address this important next step in genetic technologies.

Are you ready to network with the brightest minds shaping the future of your field? This webinar will provide a unique opportunity for a limited number of ASHG community members to connect with industry leaders, gain insights into cutting-edge advancements, and propel their career forward.

Dr. Appelbaum will discuss findings from a series of focus groups with patients, clinicians, and IRB members on return of polygenic risk scores in research. Despite strong interest in such results, they found multiple barriers to their effective use to improve health.

This workshop is intended for anybody interested in learning CRISPR-based technologies.

This workshop will showcase new data types and new features of the UCSC Genome Browser.

The goal of this session will be to review the process of developing and submitting trainee grants.

Hear from leaders on an appropriate framework for the use of germline genome editing.